Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A target-specific neosubstrate is a protein that is not normally targeted for degradation by an E3 ubiquitin ligase but becomes a target when recruited by a small molecule such as a molecular glue or PROTAC. The identity of the neosubstrate depends on the specific compound used. These compounds induce proximity between an E3 ligase (typically CRBN) and the neosubstrate, leading to ubiquitination and degradation. Examples include IKZF1, IKZF3, GSPT1, CK1α, and SALL4. The degradation of these proteins can underlie both therapeutic efficacy and adverse effects.
E3 ubiquitin ligase recruitment; induced proximity; ubiquitination and proteasomal degradation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Target-Specific Neosubstrate.